Document Detail


Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study.
MedLine Citation:
PMID:  10990148     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The efficacy of growth hormone (GH) therapy was evaluated in patients with chronic fatigue syndrome (CFS) who had peak serum GH levels below 10 microg/l during stage-controlled sleep. Twenty patients (7 men, 13 women; age range, 30-60 years) with CFS were randomized to receive placebo or GH therapy, 6.7 microg/kg/day (0.02 IU/kg/day), for 12 weeks. Following this double-blind treatment period, the 17 patients remaining in the study were given GH therapy at the above dose for an open period of 9 months. Mean (+/- SD) serum levels of insulin-like growth factor I (IGF-I) increased during GH treatment, from 173 +/- 46 microg/I to 296 +/- 89 microg/l (P < 0.001); IGF-I SDS values increased from -0.45 +/- 1.14 to +1.43 +/- 1.09 (P < 0.001). Fat-free mass and total body water were significantly increased after 12 months of treatment. Although quality of life, as assessed using two different questionnaires, did not improve significantly during GH treatment, four patients were able to resume work after a long period of sick leave.
Authors:
G Moorkens; H Wynants; R Abs
Related Documents :
18647498 - Diagnosis and treatment of pituitary microadenoma: report of 80 cases.
16935768 - Long-term primary medical therapy with somatostatin analogs in acromegaly.
3057808 - Treatment of turner's syndrome with recombinant human growth hormone (somatrem).
9834568 - A comparative study of various surgical treatments of hepatic hydatidosis with special ...
16820058 - Questions about the use of antibiotics in acute pancreatitis.
1911458 - Treatment of relapsed hodgkin's disease using a weekly chemotherapy of short duration: ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society     Volume:  8 Suppl B     ISSN:  1096-6374     ISO Abbreviation:  Growth Horm. IGF Res.     Publication Date:  1998 Apr 
Date Detail:
Created Date:  2000-10-04     Completed Date:  2000-10-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9814320     Medline TA:  Growth Horm IGF Res     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  131-3     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University Hospital Antwerp, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Body Water / drug effects
Body Weight / drug effects
Circadian Rhythm
Double-Blind Method
Fatigue Syndrome, Chronic / blood,  drug therapy*,  metabolism
Female
Human Growth Hormone / pharmacology,  therapeutic use*
Humans
Insulin-Like Growth Factor I / metabolism
Male
Middle Aged
Quality of Life
Skinfold Thickness
Sleep / physiology
Chemical
Reg. No./Substance:
12629-01-5/Human Growth Hormone; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Secretion of growth hormone in patients with chronic fatigue syndrome.
Next Document:  Binding sites for growth hormone-releasing peptide.